Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
TG Therapeutics, Inc.
(OB:
TGTX
)
5.650
USD
-0.050 (-0.88%)
Official Closing Price
/ Updated:
5:20 PM EDT, May 21, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
18,990
Open
5.710
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
5.700
Today's Range
5.600 - 5.720
52wk Range
1.850 - 6.750
Shares Outstanding
26,322,671
Dividend Yield
N/A
Top News
More News
TG Therapeutics, Inc. Announces Presentation of Phase 1 Data for Single-Agent Ublituximab (TG-1101) at the American Society of Clinical Oncology Meeting on June 2, 2013
May 16, 2013
Efficacy and Safety Data for the Phase I Dose-escalation Patients to be Updated for the Poster Presentation
Read More
from
GlobeNewswire News Releases
TG Therapeutics, Inc. Announces First Quarter 2013 Financial Results and Business Update
May 13, 2013
Investor Conference Call to be Held Tomorrow, Tuesday, May 14, 2013 at 8:30am EDT
Read More
from
GlobeNewswire News Releases
More News
Read More
TG Therapeutics, Inc. to Host Conference Call on First Quarter 2013 Financial Results and Business Update
May 10, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. to Present at the 12th Annual Needham Healthcare Conference
April 29, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. to Present at the 25th Annual ROTH Conference
March 18, 2013
from
GlobeNewswire News Releases
Roth Capital Starts TG Therapeutics (TGTX) at Buy
March 13, 2013
from
StreetInsider.com News Articles
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2012 Financial Results and Business Update
March 12, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. to Host Conference Call on Fourth Quarter and Year-End 2012 Financial Results and Business Update
March 11, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. Opens Expansion Cohorts in Its Phase I/II Trial of TG-1101 (Ublituximab) in Patients With Rituximab Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
February 11, 2013
from
GlobeNewswire News Releases
TG Therapeutics, Inc. to Present at the 15th Annual BIO CEO & Investor Conference
February 08, 2013
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here